Award recordCONTRACT

EISAI INC.

PIID VA24916J3349· VHA· 596-LEXINGTON(00596)· 6505 · DRUGS AND BIOLOGICALS· FY2016· $0 net obligations· UEI M3K9M1DWKFR5· NJ

Description

LENVIMA 14MG FOR PATIENT CARE AT LEXINGTON VAMC - DECREASE FUNDING PER POC AT LEXINGTON VAMC PHARMACY AS MEDS WERE NOT RECEIVED BY PATIENT

Base award description: LENVIMA 14MG FOR PATIENT CARE AT LEXINGTON VAMC

First action · last action
2016-07-22 · 2016-12-29
Transactions
2
First transaction's obligation
$9,360
Base + all options value (sum of deltas)
$0
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2106D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$9,360$0Base award · 2016-07-22 · this action $9,360 · running total $9,360Modification P00001 · 2016-12-29 · this action -$9,360 · running total $0
  • Base2016-07-22+$9,360= $9,360
  • Mod P000012016-12-29-$9,360= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-07-22+$9,360$9,360LENVIMA 14MG FOR PATIENT CARE AT LEXINGTON VAMC
Mod P00001· FUNDING ONLY ACTION2016-12-29−$9,360$0LENVIMA 14MG FOR PATIENT CARE AT LEXINGTON VAMC - DECREASE FUNDING PER POC AT LEXINGTON VAMC PHARMACY AS MEDS…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI M3K9M1DWKFR5)

AwardOffice · PSC / listingNet obligationsFY
36F79724D0132NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26119F0198261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$9,950FY2019
36C26019N0277260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$9,950FY2019
36C25919F0147NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$10,871FY2019
36C25919F0133NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$12,703FY2019
36C26319N0509NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS$9,950FY2019

Other recipients under 6505 from 596-LEXINGTON(00596) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24918N0172CSL BEHRING L.L.C.596-LEXINGTON(00596)$5,198FY2018
VA24917J3515CSL BEHRING L.L.C.596-LEXINGTON(00596)$5,296FY2017
VA24917J2868CSL BEHRING L.L.C.596-LEXINGTON(00596)$13,984FY2017
VA24917J2010CSL BEHRING L.L.C.596-LEXINGTON(00596)$13,984FY2017
VA24917J0696CSL BEHRING L.L.C.596-LEXINGTON(00596)$4,896FY2017

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24916J3349_3600_V797P2106D_3600 · retrieved 2026-09-26.